1. Home
  2. Health
  3. Rare Diseases

Orphan Drugs Designated in 2003
S-Z

From Mary Kugler, R.N., for About.com

Updated: December 29, 2003

About.com Health's Disease and Condition content is reviewed by our Medical Review Board

sodium pyruvate
Treatment of cystic fibrosis
Date designated: 3/31/2003

Cellular Sciences, Inc.
84 Park Avenue
P.O. Box 968
Flemington, NJ 08822

suberoylanilide hydroxamic acid (SAHA)
Treatment of multiple myeloma
Date designated: 6/12/2003

Aton Pharma, Inc.
777 Old Saw Mill River Road
Tarrytown, NY 10591-6717

tezacitabine
Treatment of cancer of the esophagus and stomach
Date designated: 1/27/2003

Chiron Corporation
4560 Horton Street
Emeryville, CA 94608-2916

tinidazole
Treatment of amebiasis (type of infection)
Date designated: 8/20/2003

Presutti Laboratories, Inc.
1607 N. Douglas Avenue
Arlington Heights, IL 60004

tranilast (trade name: Rizaben)
Treatment of malignant glioma (brain tumor)
Date designated: 12/2/2003

Angiogen Pharmaceuticals, Pty. Ltd.
Level 31, ABN AMRO Tower
88 Phillip Street
Sydney, NSW 2000

tretinoin (trade name: ATRA-IV)
Treatment of T-cell non-Hodgkin's lymphoma
Date designated: 4/11/2003

Antigenics, Inc.
34 Commerce Way
Woburn, MA 01801

vapreotide pamoate (trade name: Sanvar)
Treatment of acromegaly
Date designated: 11/4/2003

H3 Pharma, Inc.
666 Sherbrooke Street West, Suite 1400
Montreal, Quebec

Explore Rare Diseases
By Category
About.com Special Features

Learn how you can reduce your your numbers with these nutrition and exercise tips. More >

Keep yourself, and your family, happy and healthy this fall with these tips. More >

We comply with the HONcode standard for trustworthy health information: verify here.
  1. Home
  2. Health
  3. Rare Diseases
  4. Orphan Drugs
  5. Orphan Drugs Designated in 2003

©2009 About.com, a part of The New York Times Company.

All rights reserved.